Compound Detail
CHEMBL4527039
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4527039 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZNKLNWPBGRZLGW-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
368.4
MW (Da)
-0.17
ALogP
8
HBA
1
HBD
104.4
PSA (Ų)
0.69
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sepiapterin reductase CHEMBL3988583 | IC50 | 9.0 | 8.08 | 1.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sepiapterin reductase | IC50 | = | 1.0 | nM | 9.0 | Inhibition of terbium-labeled SNAP-tagged human SPR in presence of sulfasalazine... | - |
| Sepiapterin reductase | IC50 | = | 69.0 | nM | 7.16 | Inhibition of SPR in human PBMC cells assessed as reduction in BH4 production in... | - |
Data from ChEMBL 36 via Core Engine